Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer/site maintenance updates: the page now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed. These changes do not alter study content or how to access the trial details.
    Difference
    0.1%
    Check dated 2025-12-23T21:16:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.3.2, appears, replacing Revision: v3.2.0; this change is limited to metadata and does not affect the study content, eligibility criteria, or posted results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice that instructed users to consult cc.nih.gov and opm.gov for operating-status updates. The page now shows the standard study details without the extra maintenance banner.
    Difference
    0.4%
    Check dated 2025-11-18T07:25:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Visual/UI updates to the study page with no changes to core study content; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:30:46.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T07:50:48.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T04:11:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.